~~<i id='E684D5EA81'><strike id='E684D5EA81'><tt id='E684D5EA81'><pre id='E684D5EA81'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：focus 2025-09-30 11:06:45 - browse：28

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： ALS treatment from Biogen, Ionis fails in study

focus

entertainment

knowledge

focus

hotspot

focus

StephanieKeith/GettyImagesDocumentsreleasedthisweekshednewlightonanaggressivestrategyfromvapemakerJu

WSS

Covid misinformation case heads to Supreme Court

Some dementia cases could be undiagnosed liver disease

Even great ERs can’t make up for American health disparities

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

The real point of Kenneth Smith’s execution by nitrogen gas

The real point of Kenneth Smith’s execution by nitrogen gas

focus

hotspot

focus

Moonlake's readout produced a cash windfall. Risks remain

New Ultima Genomics DNA sequencer can read genome for $100

Apple is now the first public company to be valued at $3 trillion

Commercial surrogacy can be ethical, despite pope’s claims

After affirmative action ruling, medical educators look to 'holistic review'

The United States must get value

Medical leaders decry Supreme Court decision on affirmative action

Hottest summer in 2,000 years puts focus on extreme heat, health

Wildfire smoke exposes gaps in outdoor worker protections

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

entertainment

Cherokee Nation medical school graduates its first class

Supreme Court to hear if Covid misinformation is protected speech

Cherokee Nation medical school graduates its first class

STAT reporters are Pulitzer Prize finalists for investigative reporting

Galapagos to make CAR

STAT series 'Denied by AI' wins major journalism prizes

knowledge

focus

hotspot

focus